Agyemang The Second African Conference on Agricultural Technologies (ACAT2025) has taken place in Kigali, Rwanda, reigniting ...

Scientists at The Jackson Laboratory (JAX) have developed mouse models that survive premature death and enable pre-clinical ...

Using gene editing in a preclinical model, researchers at UT Southwestern Medical Center blocked the symptoms of a rare smooth muscle disease before they developed. Their findings, published in ...

Last month, a baby got the world’s first personalized gene-editing treatment. What will this mean for millions of others with ...

A gene-editing delivery system developed by UT Southwestern Medical Center researchers simultaneously targeted the liver and lungs of a preclinical model of a rare genetic disease known as alpha-1 ...

(Reuters) -Eli Lilly is in advanced talks to acquire gene editing startup Verve Therapeutics for up to $1.3 billion, aiming to strengthen its pipeline of experimental medicines, the Financial Times ...

Gene editing is traditionally done using CRISPR-Cas9 to make a physical change in the DNA. A guide RNA directs the Cas9 protein to a specific DNA location, where Cas9 completely severs the DNA ...

Researchers develop a personalized base-editing therapy within 6 months for a newborn with a rare genetic disease — using rapid workflow that could be customized to other patients too.

Preterm birth can be severely harmful to neonates. Currently, no effective clinical treatments target in utero inflammation ...

KJ Muldoon, a 10-month-old baby who sparked nationwide headlines after receiving a first-of-its kind gene-editing treatment, was released from the hospital this week. KJ has spent the majority of ...

Scientists at the San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), Milan, have found that gene editing using CRISPR-Cas9 in combination with AAV6 vectors can trigger inflammatory and ...

After spending over 300 days at the Children's Hospital of Philadelphia (CHOP), 9-month-old KJ Muldoon has been released from the hospital after receiving personalized CRISPR gene editing therapy.